Gemmer Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-65
Closed -$1K – 216
2022
Q1
$1K Hold
65
– – ﹤0.01% 1179
2021
Q4
$2K Hold
65
– – ﹤0.01% 1163
2021
Q3
$2K Hold
65
– – ﹤0.01% 1175
2021
Q2
$2K Hold
65
– – ﹤0.01% 1390
2021
Q1
$2K Hold
65
– – ﹤0.01% 1356
2020
Q4
$1K Hold
65
– – ﹤0.01% 1385
2020
Q3
$1K Buy
65
+7
+12% +$121 ﹤0.01% 1276
2020
Q2
$1K Sell
58
-48
-45% -$846 ﹤0.01% 1251
2020
Q1
$2K Sell
106
-94
-47% -$2.27K ﹤0.01% 1027
2019
Q4
$6K Buy
+200
New +$5.2K ﹤0.01% 852
2019
Q2
– Sell
-44
Closed -$1K – 1372
2019
Q1
$1K Buy
+44
New +$1.05K ﹤0.01% 1334
2018
Q4
– Sell
-49
Closed -$1K – 1359
2018
Q3
$1K Buy
+49
New +$1.12K ﹤0.01% 1340

Other funds holding BHC

Gemmer Asset Management's BHC Position: Q2 2022 in Review

Gemmer Asset Management sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 65 shares — an estimated $1K sold.

Gemmer Asset Management first reported a position in BHC in Q3 2018 and held it in 12 quarters. The position peaked at $6K in Q4 2019. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Gemmer Asset Management reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Gemmer Asset Management sold 65 Bausch Health shares in Q2 2022, an estimated $1K.
  • Gemmer Asset Management first reported a position in Bausch Health in Q3 2018 and held it in 12 quarters.
  • Gemmer Asset Management's Bausch Health position peaked at $6K in Q4 2019.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.